Career Enhancement Program

职业提升计划摘要/摘要 职业提升计划(CEP)的目标是开发训练有素、出类拔萃的新员工 致力于早期发现、预防和治疗的转化性研究的研究人员 子宫内膜癌。这些研究人员和他们的研究最终将有助于降低发病率和 这种疾病的死亡率。CEP将招聘和培训医生和基础科学家，使他们能够 成为子宫内膜癌领域的高技能翻译调查人员；2)提供具体的 子宫内膜癌研究方面的知识，将提高获奖者进行创新的能力 将直接影响对这种疾病的理解和治疗的翻译科学；以及3)重新定向 已经在子宫内膜癌研究中表现出相当大的科学前景的个人。至 为了实现这一目标，孢子CEP将在长达两年的时间内每年提供至少两个5万美元的奖项， 资金来自孢子和/或MD Anderson的配套基金或慈善基金。我们将积极进取 招募最有前途的新研究人员，制定个性化的发展计划，包括临床和 实验室导师和指导委员会，资助和手稿写作指导，领导力培训， 与子宫内膜癌学者建立联系，完成并出版一本翻译的子宫内膜癌 同行评议期刊上的手稿。CEP将鼓励和支持获奖者在国家 开会。CEP将由医学博士、医学教育副总裁戴安娜·博杜尔卡领导 安德森和妇科肿瘤学家，以及大卫·格申森，医学博士，前妇科主任 安德森医学院妇科肿瘤科。孢子公司医学博士拉塞尔·布罗德杜斯将提供监督 对于CEP来说，因为孢子领导层认识到这一计划的重要性。九位前CEP奖获得者 在目前的孢子竞争更新中发挥着重要作用，要么是作为项目的联合调查员， 领导临床试验，为研究项目的发展提供重要的初步数据；或 在孢子外部顾问委员会任职。

Career Enhancement Program SUMMARY/ABSTRACT The goal of the Career Enhancement Program (CEP) is to develop highly trained, exceptional new investigators dedicated to translational research in the early detection, prevention, and treatment of endometrial cancer. These investigators and their research will ultimately help to reduce the morbidity and mortality from this disease. The CEP will 1) recruit and train physicians and basic scientists to enable them to become highly skilled translational investigators in the field of endometrial cancer; 2) provide specific knowledge of research in endometrial cancer that will enhance the ability of awardees to conduct innovative translational science that will directly impact the understanding and treatment of this disease; and 3) re-direct individuals who have already shown considerable scientific promise into endometrial cancer research. To achieve this goal, the SPORE CEP will provide at least two awards of $50,000 annually for up to two years, funded from the SPORE and/or matching funds or philanthropic funds from MD Anderson. We will aggressively recruit the most promising new investigators and institute an individualized development plan with clinical and laboratory mentors and a mentoring committee, coaching in grant and manuscript writing, leadership training, networking with endometrial cancer scholars, and completing and publishing a translational endometrial cancer manuscript in a peer-reviewed journal. The CEP will encourage and support awardee presentations at national meetings. The CEP will be led by Diana Bodurka, M.D., the Vice President of Medical Education at MD Anderson and a gynecologic oncologist, and David Gershenson, M.D., the former Chair of the Department of Gynecologic Oncology at MD Anderson. Russell Broaddus, M.D., Ph.D., SPORE Co-PI, will provide oversight to the CEP, as SPORE leadership recognizes the importance of this program. Nine previous CEP awardees are playing major roles in the current SPORE competitive renewal, either as co-investigators on projects, leading clinical trials, contributing important preliminary data for the development of a research project, or serving on the SPORE External Advisory Board.